Dormagen, Germany

Helene Faber

USPTO Granted Patents = 2 

Average Co-Inventor Count = 13.1

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):

Title: Helene Faber – Pioneering Innovations in Pharmaceutical Chemistry

Introduction

Helene Faber, an accomplished inventor based in Dormagen, Germany, has made significant contributions to the field of pharmaceutical chemistry. With a total of two patents to her name, her innovative work focuses on the development of novel processes for the preparation of pharmaceutically active compounds.

Latest Patents

Among her latest patents, Faber has developed a groundbreaking process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl][2-(2-{[3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms. This invention highlights a novel crystallization process for the preparation of different monohydrate forms, which are essential for treating various cardiopulmonary disorders. The patent emphasizes the inhalative treatment of conditions such as pulmonary arterial hypertension and chronic lung diseases, showcasing the pharmaceutical potential of her compounds.

Career Highlights

Helene Faber's professional journey includes significant roles at Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. Her work in these prestigious companies has allowed her to gain invaluable experience, further enhancing her innovative capabilities in pharmaceutical development.

Collaborations

Throughout her career, Faber has collaborated with esteemed colleagues such as Britta Olenik and Birgit Keil. These collaborations have facilitated knowledge exchange and the successful advancement of research projects in pharmaceutical chemistry.

Conclusion

Helene Faber's contributions to the field of pharmaceutical chemistry exemplify the spirit of innovation. Her patents, aimed at improving the treatment of complex cardiopulmonary disorders, reflect her commitment to developing effective medical solutions. As her career progresses, it will be intriguing to see how her work continues to impact the pharmaceutical industry and contributes to the betterment of health care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…